Previous Close | 0.1000 |
Open | 0.0000 |
Bid | 0.1250 x N/A |
Ask | 0.1500 x N/A |
Day's Range | 0.0000 - 0.0000 |
52 Week Range | |
Volume | |
Avg. Volume | 71,612 |
Market Cap | 15.363M |
Beta (5Y Monthly) | 0.33 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0660 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for RAMM.CN
TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”). On February 22, 2022, the Company announced that, for reasons set out in its news release of February 22, 2022, the filing of its annual audited financial statements for the year ended October 31, 2021, the accompanying management's discussion and analysis and the related CEO and CFO certifications (collectively, the "Annual Filings") would not be filed by the prescribed deadline of February 28, 2022 (the “